As demand for fertility care accelerates and private equity-backed platforms mature, Rick provides strategic counsel on regulatory, transactional, and M&A matters. His insights have been featured in coverage of the fertility sector’s emergence as a bright spot in an otherwise sluggish healthcare deal market. Go to the article.